TY - JOUR
AU - D. P. Watson
AU - P. Phalen
AU - S. Medcalf
AU - S. Messmer
AU - A. McGuire
A1 - 
AD - Chestnut Health Systems, Lighthouse Institute, 221 W Walton St, Chicago, IL, 60610, USA. dpwatson@chestnut.org.; Division of Psychiatric Services Research, University of Maryland School of Medicine, 655 W Baltimore St, Baltimore, MD, 21201, USA.; Indiana University Health, 950 N Meridian St, Ste 900, Indianapolis, IN, 46204, USA.; Department of Academic Internal Medicine and Pediatrics, University of Illinois at Chicago, 840 S Wood St, Chicago, IL, 60612, USA.; Department of Social and Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, 1050 Wishard Blvd, Indianapolis, IN, 46202, USA.; Richard L. Roudebush VAMC, Health Services Research and Development, 1481 W 10th St (11H) Rm C8108, Indianapolis, IN, 46202, USA.
AN - 36774507
BT - Subst Abuse Treat Prev Policy
C5 - Opioids & Substance Use; HIT & Telehealth
CP - 1
DA - Feb 11
DO - 10.1186/s13011-023-00523-4
DP - NLM
ET - 20230211
IS - 1
JF - Subst Abuse Treat Prev Policy
PY - 2023
SN - 1747-597x
SP - 9
ST - Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services
T1 - Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services
T2 - Subst Abuse Treat Prev Policy
TI - Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services
U1 - Opioids & Substance Use; HIT & Telehealth
U3 - 10.1186/s13011-023-00523-4
VL - 18
VO - 1747-597x
Y1 - 2023
ER -